Loading data for RGNT — first visit, this takes a few seconds.
Regentis Biomaterials Ltd... (RGNT)
NYSE American: RGNT
· Precio en tiempo real · USD
2.23
+0.24 (12.06%)
Al cierre: Aug 19, 2026, 3:59 PM
2.13
-3.40%
Premercado: 8:58 AM
Regentis Biomaterials Ltd. (RGNT) Stock Price, Analysis & Data
12.06% (1D)
| Precio de compra | n/a |
| Capitalización de mercado | 15.66M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | -13.69M |
| Beta | n/a |
| EPS (TTM) | -27.07 |
| Ratio PER (TTM) | n/a |
| Adelante PE | n/a |
| P/B (TTM) | 2.43 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 196,923 |
| Volumen medio (20D) | 5,409,869 |
| Abierto | 2.00 |
| Anterior Cerrar | 1.99 |
| Rango del día | 1.99 - 2.47 |
| Rango de 52 semanas | 1.23 - 15.50 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de RGNT
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the ...
Industria Medical Instruments & Supplies
Sector Healthcare
IPO Fecha Dec 4, 2025
Empleados n/a
Bolsa de Valores NYSE American
Símbolo bursátil RGNT
Sitio web https://www.regentis.co.il
Desempeño financiero
En 2025, los ingresos de Regentis Biomaterials fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -13.65M, una disminución de -384.27%.
Estados financieros
